UNSPSC 51101618: Taurolidine

This classification denotes an antibiotic with the molecular formula C7H16N4O4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8OBZ1M4V3V, chemically known as 4,4-methylenebis(tetrahydro-1,2,4-thiadiazine 1,1-dioxide) but generally known as taurolidine, which bears US NIH Compound Identifier 29566. European Medicines Agency schedules Taurolidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10837MIG.

UNSPSC 51101618 Taurolidine, a Commodity code, nominally names a single pharmaceutical agent, but recent state and local solicitations under this code span a broader pharmaceutical and medical supply procurement landscape — including naloxone procurement, pharmacy benefit program management, emergency medical supplies, and generic pharmaceutical contracting through cooperative purchasing vehicles. State and local governments are buying pharmaceutical products, medical consumables, and emergency response supplies through a mix of direct purchasing, cooperative agreements, and information-gathering initiatives. Issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire and rescue divisions (City of Tampa), and cooperative purchasing alliances serving multiple jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance, MMCAP). The activity reflects demand across health departments, emergency services, and pharmacy benefit administration rather than procurement of taurolidine specifically.

Recent opportunities cluster in Florida, Texas, Minnesota, and Oregon. Seminole County released IFB 60459723LAS on June 30, 2026, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries, response due July 26, 2023. The City of Tampa issued Bid 26P00145 on March 25, 2026, for 169 line items of medical and first aid supplies for its Fire Department Rescue Division, estimated at $700,000, designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5% bid discount, response due March 13, 2026. The Minnesota Department of Administration's Office of State Procurement released RFP S1070000015802 on January 20, 2026, for generic multi-source pharmaceuticals and OTC products through MMCAP, with proposals due March 26, 2026. Texas Health and Human Services Commission posted RFI HHS0017013 on April 3, 2026, seeking vendor capabilities for direct-to-manufacturer prescription programs — an exploratory procurement mechanism rather than a formal bid round. The code shows material activity across municipal, county, state, and cooperative procurement channels but with limited clarity on taurolidine-specific demand.